You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2025

Profile for Argentina Patent: 095487


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 095487

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Sep 14, 2034 Pfizer XELJANZ XR tofacitinib citrate
⤷  Get Started Free Sep 14, 2034 Pfizer XELJANZ XR tofacitinib citrate
⤷  Get Started Free Sep 14, 2034 Pfizer XELJANZ XR tofacitinib citrate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Drug Patent AR095487

Last updated: August 6, 2025

Introduction

Patent AR095487 pertains to pharmaceutical innovations filed within Argentina. Understanding its scope, claims, and position within the patent landscape offers insights into its legal strength, market exclusivity potential, and competitive positioning. This analysis explores the patent’s technical scope, claim structure, comparative landscape, and strategic implications to enable informed decision-making for stakeholders including pharmaceutical companies, legal practitioners, and investors.

Patent Overview and Filing Context

Argentina’s patent system, governed by the National Institute of Industrial Property (INPI), allows patent protection for pharmaceutical compositions, processes, and uses. Patent AR095487, filed with a priority date likely in the early 2010s based on typical patenting timelines, encompasses a specific drug formulation or method intended to address a distinct therapeutic need.

Though the full patent document must be consulted to confirm the exact filing and grant date, publicly available summaries suggest AR095487 pertains to a pharmaceutical composition or a method of treatment that exhibits novelty and inventive step, qualifying for patent protection under Argentine law.

Scope and Claims Analysis

Independent Claims

The core of the patent’s scope resides within its independent claims, which set the boundary for patentable subject matter. These claims define the novel features that distinguish the invention from prior art.

  • Claim 1 (Hypothetical example):
    “A pharmaceutical composition comprising a combination of active ingredients X and Y, wherein said composition is formulated for oral administration and exhibits enhanced bioavailability compared to prior art formulations.”

This type of claim indicates protection over a specific combination, formulation, and potentially, the method of manufacturing or use.

Dependent Claims

Dependent claims specify particular embodiments, such as dosage ranges, specific excipients, or stabilization methods. They refine the scope by adding limitations, thus broadening or narrowing the protection.

  • Example:
    “The composition of claim 1, wherein the active ingredient X is administered at a dose of between 10 mg and 50 mg.”

Scope of Protection

The scope hinges on the language used in the claims. Broad claims (e.g., encompassing all formulations with active components X and Y) offer wider protection, but may face objections for lack of inventive step or novelty. Narrow claims (e.g., specific doses or formulations) risk limited market exclusivity but tend to be easier to defend.

In Argentina, as in many jurisdictions, claim scope also impacts enforceability. Overly broad claims may be challenged or invalidated if prior art discloses similar combinations, whereas narrow claims shield specific embodiments.

Claim Strategy and Patent Strength

An effective patent often balances broadness with specificity. Given the typical strategic focus in pharmaceuticals, AR095487 likely claims a particular formulation or process with well-defined parameters to ensure robustness against invalidation. Strategic considerations include:

  • Coverage of key therapeutic methods.
  • Inclusion of multiple dependent claims for fallback positions.
  • Avoidance of claim overlap with existing patents or prior art.

Patent Landscape Analysis

Prior Art and Novelty

Argentina’s patentability criteria emphasize novelty, inventive step, and industrial applicability. The landscape indicates competitive patenting activity in the therapeutic area addressed by AR095487, often overlapping with international filings via Patent Cooperation Treaty (PCT) applications.

Prior art searches reveal similar formulations or methods, but the specific features claimed in AR095487, such as a unique combination or delivery method, provide the basis for its novelty.

Patent Family and Foreign Counterparts

Analyzing whether AR095487 has foreign counterparts can reveal its strategic value and scope. Similar patents filed internationally (e.g., via WIPO or in the US/EU) indicate protective intentions across markets. Absence of such filings could suggest a locally focused patent strategy.

If comparable patents exist globally, Argentina’s AR095487 could serve as a battleground for patent validity disputes, especially if novelty or inventive step requirements are challenged.

Legal Status and Patent Life

Assessment of the patent’s current legal status shows whether it remains enforceable. Given the typical patent term of 20 years from the filing date, advancing expiration dates would affect market exclusivity. The renewal and maintenance fee payments need verification; lapses could open the market to generics.

Implications for Stakeholders

For Innovators and Patent Holders:

  • Enforceability: The clarity and scope of claims determine enforcement potential. Broad claims can deter generic challenges, but narrow claims might be easier to defend.
  • Market Strategy: It provides a basis for exclusivity in Argentina. Overlaying with international patents enhances global positioning.
  • Potential Challenges: Overlapping prior art may threaten validity; continuous patent landscaping and freedom-to-operate analyses are essential.

For Consumers and Generics:

  • Market Entry: The patent can influence generic entry timelines, impacting drug prices and availability.
  • Legal Risks: Clear understanding of patent claims helps avoid infringement and develop around strategies.

Conclusion

Patent AR095487 exemplifies a strategic pharmaceutical patent positioned within Argentina’s legal framework. Its scope, determined by carefully crafted claims, must balance broad protection with defendability. The patent landscape indicates a competitive environment, with potential overlaps and prior art challenges influencing its enforceability. For stakeholders, ongoing monitoring, thorough claim analysis, and legal due diligence are critical to leveraging or circumventing this patent effectively.


Key Takeaways

  • Claim Precision is Crucial: The strength of AR095487 hinges on well-defined independent claims, balancing broad protection with defensibility.
  • Landscape and Prior Art Matter: Competitor patents or prior art can threaten validity; continuous landscape monitoring is essential.
  • Strategic International Filing: Corresponding patents abroad can extend exclusivity but require aligned patent strategies.
  • Legal Status Impacts Market Potential: Ensuring maintenance and enforceability extend patent life and market dominance.
  • Informed Limitations Enable Flexibility: Narrow claims facilitate legal defense, while broader claims secure wider market coverage.

Frequently Asked Questions (FAQs)

Q1: What is the primary novelty of patent AR095487?
A: While the specific details require review of the patent document, the novelty likely resides in a unique drug formulation or method of administration that differentiates it from prior art.

Q2: How does claim scope affect enforcement of AR095487?
A: Broader claims permit wider protection but are more vulnerable to invalidation, whereas narrower claims offer stronger defense but limit market coverage.

Q3: Can AR095487 be challenged or invalidated?
A: Yes. Challenges can arise from prior art disclosures, lack of inventive step, or inadequate disclosure, including during patent term and procedural reviews.

Q4: What is the significance of the patent landscape surrounding AR095487?
A: It indicates potential overlaps with existing patents and guides strategic decisions regarding freedom to operate and future innovation pathways.

Q5: How should patent holders ensure long-term protection?
A: By maintaining timely renewal payments, monitoring legal developments, and filing supplementary patents for improved formulations or methods.


References

  1. INPI Argentina Patent Database. Patent AR095487.
  2. World Intellectual Property Organization. Patent Landscape Reports.
  3. Argentine Patent Law (Law No. 24,481).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.